Fidelity Disruptive Medicine ETF (FMED)

Assets	$47.16M
Expense Ratio	0.50%
PE Ratio	40.46
Shares Out	2.12M
Dividend (ttm)	$0.11
Dividend Yield	0.49%
Ex-Dividend Date	Dec 20, 2024
Payout Ratio	19.86%
1-Year Return	-2.51%

Volume	n/a
Open	n/a
Previous Close	22.59
Day's Range	n/a
52-Week Low	20.69
52-Week High	26.79
Beta	n/a
Holdings	66
Inception Date	Apr 16, 2020

About FMED

Fund Home Page

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is issued by Fidelity.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: FMED
• ETF Provider: Fidelity

Top 10 Holdings

39.05% of assets

Name	Symbol	Weight
Boston Scientific Corporation	BSX	6.09%
Fidelity Securities Lending Cash Central Fund	n/a	5.27%
UnitedHealth Group Incorporated	UNH	3.86%
argenx SE	ARGX	3.81%
Intuitive Surgical, Inc.	ISRG	3.71%
Penumbra, Inc.	PEN	3.55%
Danaher Corporation	DHR	3.41%
Insulet Corporation	PODD	3.24%
Waystar Holding Corp.	WAY	3.14%
Alnylam Pharmaceuticals, Inc.	ALNY	2.98%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 20, 2024	$0.112	Dec 24, 2024
Jun 21, 2024	$0.001	Jun 25, 2024